pubmed-article:16398403 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16398403 | lifeskim:mentions | umls-concept:C0205474 | lld:lifeskim |
pubmed-article:16398403 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
pubmed-article:16398403 | lifeskim:mentions | umls-concept:C0027912 | lld:lifeskim |
pubmed-article:16398403 | lifeskim:mentions | umls-concept:C0031437 | lld:lifeskim |
pubmed-article:16398403 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
pubmed-article:16398403 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:16398403 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:16398403 | pubmed:dateCreated | 2006-1-9 | lld:pubmed |
pubmed-article:16398403 | pubmed:abstractText | The prevalence and distribution of neuroendocrine differentiation in non-small cell lung cancer (NSCLC) was estimated by assays for synaptophysin (SYN), chromogranin A (CgA), Leu7 and neuron-specific enolase (NSE). Serum NSE and CgA were determined in parallel to find the values of these markers for distinguishing neuroendocrine differentiation in NSCLC. Fifty-eight resected NSCLC specimens and 34 sera of NSCLC patients entered the study. Neuroendocrine differentiation was graded according to the percentage of neuroendocrine tumor cells as NE0--0%, NE1-NE4--1%->76%. Serum NSE <12.5 ng/mL and serum CgA <46 U/L were taken as cutoff levels. | lld:pubmed |
pubmed-article:16398403 | pubmed:language | eng | lld:pubmed |
pubmed-article:16398403 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16398403 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16398403 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16398403 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16398403 | pubmed:issn | 0393-6155 | lld:pubmed |
pubmed-article:16398403 | pubmed:author | pubmed-author:SlodkowskaJJ | lld:pubmed |
pubmed-article:16398403 | pubmed:author | pubmed-author:ZychJJ | lld:pubmed |
pubmed-article:16398403 | pubmed:author | pubmed-author:DemkowUU | lld:pubmed |
pubmed-article:16398403 | pubmed:author | pubmed-author:SzturmowiczMM | lld:pubmed |
pubmed-article:16398403 | pubmed:author | pubmed-author:Rowinska-Zakr... | lld:pubmed |
pubmed-article:16398403 | pubmed:author | pubmed-author:Roszkowski-Sl... | lld:pubmed |
pubmed-article:16398403 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16398403 | pubmed:volume | 20 | lld:pubmed |
pubmed-article:16398403 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16398403 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16398403 | pubmed:pagination | 217-26 | lld:pubmed |
pubmed-article:16398403 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:16398403 | pubmed:meshHeading | pubmed-meshheading:16398403... | lld:pubmed |
pubmed-article:16398403 | pubmed:meshHeading | pubmed-meshheading:16398403... | lld:pubmed |
pubmed-article:16398403 | pubmed:meshHeading | pubmed-meshheading:16398403... | lld:pubmed |
pubmed-article:16398403 | pubmed:meshHeading | pubmed-meshheading:16398403... | lld:pubmed |
pubmed-article:16398403 | pubmed:meshHeading | pubmed-meshheading:16398403... | lld:pubmed |
pubmed-article:16398403 | pubmed:meshHeading | pubmed-meshheading:16398403... | lld:pubmed |
pubmed-article:16398403 | pubmed:meshHeading | pubmed-meshheading:16398403... | lld:pubmed |
pubmed-article:16398403 | pubmed:meshHeading | pubmed-meshheading:16398403... | lld:pubmed |
pubmed-article:16398403 | pubmed:meshHeading | pubmed-meshheading:16398403... | lld:pubmed |
pubmed-article:16398403 | pubmed:meshHeading | pubmed-meshheading:16398403... | lld:pubmed |
pubmed-article:16398403 | pubmed:meshHeading | pubmed-meshheading:16398403... | lld:pubmed |
pubmed-article:16398403 | pubmed:meshHeading | pubmed-meshheading:16398403... | lld:pubmed |
pubmed-article:16398403 | pubmed:meshHeading | pubmed-meshheading:16398403... | lld:pubmed |
pubmed-article:16398403 | pubmed:articleTitle | Neuroendocrine phenotype of non-small cell lung carcinoma: immunohistological evaluation and biochemical study. | lld:pubmed |
pubmed-article:16398403 | pubmed:affiliation | Department of Telepathology, The National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland. j.slodkowska@igichp.edu.pl | lld:pubmed |
pubmed-article:16398403 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16398403 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |